BUDAPEST (Reuters) -Higher U.S. tariffs may make it challenging for Hungarian pharmaceutical company Richter to export some products to the United States, but they won't apply to its flagship ...
Zacks Investment Research on MSN
Will AbbVie's neuroscience segment continue to aid top line in 2026?
AbbVie ABBV reported encouraging fourth-quarter and full-year 2025 results last month. While the company’s immunology ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results